GB/T 16886.20-2015
Biological evaluation of medical devices.Part 20:Principles and methods for immunotoxicology testing of medical devices (English Version)

Standard No.
GB/T 16886.20-2015
Language
Chinese, Available in English version
Release Date
2015
Published By
General Administration of Quality Supervision, Inspection and Quarantine of the People‘s Republic of China
Latest
GB/T 16886.20-2015
Scope
This part of GB/T 16886 gives an overview of immunotoxicology on the potential immunotoxicity of medical devices. This section also gives guidance on methods used to test the immunotoxicity of different types of medical devices. This section is based on several publications written over the past few decades by different expert groups in immunotoxicology, which has developed as a separate branch within the field of toxicology. The current state of knowledge regarding immunotoxicity is described in Appendix A, and an overview of clinical experience in immunotoxicology relevant to medical devices to date is given in Appendix B.

GB/T 16886.20-2015 Referenced Document

  • GB/T 16886.1-2001 Biological evaluation of medical devices--Part 1: Evaluation and testing
  • GB/T 16886.10-2005 Biological evaluation of medical devices.Part 10:Tests for irritation and delayed-type hypersensitivity
  • GB/T 16886.11-1997 Biological evaluation of medical devices--Part 11: Tests for systemic toxicity
  • GB/T 16886.2-2000 Biological evaluation of medical devices--Part 2: Animal welfare requirements
  • GB/T 16886.6-1997 Biological evaluation of medical devices--Part 6: Tests for local effects after implantation
  • YY/T 0316-2008 Medical devices.Application of risk management to medical devices

GB/T 16886.20-2015 history

  • 2015 GB/T 16886.20-2015 Biological evaluation of medical devices.Part 20:Principles and methods for immunotoxicology testing of medical devices
Biological evaluation of medical devices.Part 20:Principles and methods for immunotoxicology testing of medical devices

GB/T 16886.20-2015 -All Parts

GB/T 16886.1-2022 Biological evaluation of medical devices—Part 1: Evaluation and testing within a risk management process GB/T 16886.10-2017 Biological evaluation of medical devices—Part 10: Tests for irritation and skin sensitization GB/T 16886.11-2021 Biological evaluation of medical devices—Part 11: Tests for systemic toxicity GB/T 16886.12-2023 Biological Evaluation of Medical Devices Part 12: Sample Preparation and Reference Materials GB/T 16886.13-2017 Biological evaluation of medical devices—Part 13: Identification and quantification of degradation products from polymeric medical devices GB/T 16886.14-2003 Biological evaluation of medical devices--Part 14: Identification and quantification of degradation products from ceramics GB/T 16886.15-2022 Biological evaluation of medical devices—Part 15: Identification and quantification of degradation products from metals and alloys GB/T 16886.16-2021 Biological evaluation of medical devices—Part 16: Toxicokinetic study design for degradation products and leachables GB/T 16886.17-2005 Biological evaluation of medical devices.Part 17:Establishment of allowable limits for leachable substances GB/T 16886.18-2022 Biological evaluation of medical devices—Part 18: Chemical characterization of medical device materials within a risk management process GB/T 16886.19-2022 Biological evaluation of medical devices—Part 19: Physico-chemical, morphological and topographical characterization of materials GB/T 16886.2-2011 Biological evaluation of medical devices.Part 2: Animal welfare requirements GB/T 16886.20-2015 Biological evaluation of medical devices.Part 20:Principles and methods for immunotoxicology testing of medical devices GB/T 16886.23-2023 Biological Evaluation of Medical Devices Part 23: Stimulation Test GB/T 16886.3-2019 Biological evaluation of medical devices—Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity GB/T 16886.4-2022 Biological evaluation of medical devices—Part 4: Selection of tests for interactions with blood GB/T 16886.5-2017 Biological Evaluation of Medical Devices Part 5: In Vitro Cytotoxicity Tests GB/T 16886.6-2022 Biological evaluation of medical devices—Part 6:Tests for local effects after implantation GB/T 16886.7-2015 Biological evaluation of medical devices—Part 7: Ethylene oxide sterilization residuals GB/T 16886.9-2022 Biological Evaluation of Medical Devices Part 9: Qualitative and Quantitative Framework for Potential Degradation Products



Copyright ©2024 All Rights Reserved